Canoo Inc. (NASDAQ: GOEV), an EV start-up that aspires to be a high-tech advanced mobility company, announced the signing of a definitive agreement with Walmart (NYSE: WMT) for 4,500 all-electric delivery vehicles beginning with the lifestyle delivery vehicle (LDV). The contract also has an option...
Greenwich LifeSciences, Inc. (NASDAQ: GLSI), a clinical-stage pharmaceutical company, developing immunotherapy to prevent breast cancer recurrence in patients who previously underwent surgery, announced the removal of the clinical hold on the Phase III Flamingo-01 clinical trial by the U.S Food and Drug Administration (FDA). The FDA...
Emergent BioSolutions, Inc. (NYSE: EBS), a life sciences company is developing a portfolio of vaccines and therapeutics for urgent health threats, announced the acceptance of a Biologics License Application (BLA) for AV7909 (Anthrax Vaccine Adsorbed, Adjuvanted) by the U.S. Food and Drug Administration (FDA). The...
Aligos Therapeutics, Inc. (NASDAQ: ALGS), a clinical-stage biotechnology Company announced the discontinuation of dosing in the first cohort of its candidate ALG-020572, intended for the treatment of chronic hepatitis B. The dosing was stopped after a patient experienced a serious adverse event (SAE) and a...
AST SpaceMobile, Inc. (NASDAQ: ASTS) announced the signing of a multi-launch agreement with Space Exploration Technologies Corp. The agreement covers the launch of the BlueWalker 3 test satellite (BW3), intended to be launched this summer, along with the launch of the first BlueBird satellite, besides...
This week we bring to you four companies, namely Sunworks (NASDAQ: SUNW), Progenity Inc (NASDAQ: PROG), Upland Software Inc (NASDAQ: UPLD) and Purple Innovation Inc (NASDAQ: PRPL) that could turn out be to vulnerable investments, in view of the challenges being faced by these companies, such as...
ShotSpotter, Inc. (NASDAQ: SSTI) manufacturers ShotSpotter® Flex™, a gun detection location and forensic analyses system, which use acoustic sensors with audio triangulation capability, to pinpoint where shots are fired. The Company offers an end-to-end precision policing platform that enables law enforcement to pre-empt and provide...
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a commercial-stage biopharmaceutical focused on creating novel therapies for treatment of cancer, announced that a crucial phase 3 trial of QINLOCK in patients with gastrointestinal stromal tumor (GIST) previously treated with imatinib did not meet the primary endpoint of improved...
Technology Industry has been focused on leaving the COVID-19 pandemic behind, and marching ahead with its innovations and breakthroughs, be it critical security systems, innovative marketing solutions or cutting-edge data analytics and search technology. We look at some technology companies that are impervious to the scare...
Insider selling cannot be the sole indicator for investing in a stock, but it would be wise to make a note of the buying and selling activities to gauge a company’s prospects or the lack thereof. While insiders buying or selling the Company’s stock could...
